• Login
    View Item 
    •   Digital Repository Home
    • TCNJ Scholars (Faculty and Student Research)
    • Faculty Research
    • Mathematics & Statistics Department
    • View Item
    •   Digital Repository Home
    • TCNJ Scholars (Faculty and Student Research)
    • Faculty Research
    • Mathematics & Statistics Department
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Global Reactivation of Epigenetically Silenced Genes in Prostate Cancer

    Thumbnail
    Date
    2010
    Author
    Ochs, Michael F.
    Ibragimova, Ilsiya
    Cáceres, Inmaculada Ibáñez de
    Hoffman, Amanda R.
    Potapova, Anna
    Dulaimi, Essel
    Al-Saleem, Tahseen
    Hudes, Gary R.
    Cairns, Paul
    Metadata
    Show full item record
    Abstract
    Abstract
    Transcriptional silencing associated with aberrant promoter hypermethylation is a common mechanism of inactivation of tumor suppressor genes in cancer cells. To globally profile the genes silenced by hypermethylation in prostate cancer, we screened a whole genome expression microarray for genes reactivated in the LNCaP, DU-145, PC-3, and MDA2b prostate tumor cell lines after treatment with the demethylating drug 5-aza-2-deoxycytidine and the histone deacetylation–inhibiting drug trichostatin A. A total of 2,997 genes showed at least 2-fold upregulation of expression after drug treatment in at least one prostate tumor cell line. For validation, we examined the first 45 genes, ranked by upregulation of expression, which had a typical CpG island and were known to be expressed in the normal cell counterpart. Two important findings were, first, that several genes known to be frequently hypermethylated in prostate cancer were apparent, and, second, that validation studies revealed eight novel genes hypermethylated in the prostate tumor cell lines, four of which were unmethylated in normal prostate cells and hypermethylated in primary prostate tumors (SLC15A3, 66%; KRT7, 54%; TACSTD2, 17%; GADD45b, 3%). Thus, we established the utility of our screen for genes hypermethylated in prostate cancer cells. One of the novel genes was TACSTD2/TROP2, a marker of human prostate basal cells with stem cell characteristics. TACSTD2 was unmethylated in prostatic intraepithelial neoplasia and may have utility in emerging methylation-based prostate cancer tests. Further study of the hypermethylome will provide insight into the biology of the disease and facilitate translational studies in prostate cancer
    Citation:
    Ibragimova, I., de Caceres, I. I., Hoffman, A. M., Potapova, A., Dulaimi, E., Cairns, P., & ... Ochs, M. F. (n.d). Global Reactivation of Epigenetically Silenced Genes in Prostate Cancer. Cancer Prevention Research, 3(9), 1084-1092.
    Description
    File not available for download due to copyright restrictions
    URI
    https://dx.doi.org/10.1158/1940-6207.CAPR-10-0039
    Collections
    • Mathematics & Statistics Department

    DSpace software copyright © 2002-2016  DuraSpace
    | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    DSpace software copyright © 2002-2016  DuraSpace
    | Send Feedback
    Theme by 
    Atmire NV